查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1865393

全球後生元外用市場：預測（至2032年）－依產品類型、活性成分、應用、最終使用者、通路和地區進行分析

Postbiotic Topicals Market Forecasts to 2032 - Global Analysis By Product Type, Active Ingredient, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球益生元外用產品市場價值將達到 1.382 億美元，到 2032 年將達到 2.677 億美元。

預計在預測期內，後生元外用產品將以9.9%的複合年成長率成長。後生元外用產品是一種以非活性微生物產品（例如酵素、胜肽和代謝物）配製而成的護膚配方，旨在維護皮膚健康。後生元不含活菌，因此更穩定，更適合外用。這些生物活性化合物有助於增強皮膚屏障、減少發炎並促進微生物群平衡。後生元外用產品廣泛應用於皮膚科和化妝品領域，可為敏感肌、痤瘡肌或老齡化肌提供針對性功效，並避免了活性菌叢帶來的風險。

皮膚問題增多，例如痤瘡、濕疹和皮膚敏感。

痤瘡、濕疹和敏感肌膚等皮膚問題的日益增多，促使消費者對注重微生物群的護膚越來越感興趣。這催生了對溫和配方、支持皮膚屏障功能的需求。後生元具有抗炎和舒緩功效，且穩定性優於活性菌，因此非常適合敏感肌膚。臨床證據和消費者對潔淨標示產品日益成長的需求進一步強化了這一趨勢。隨著消費者尋求針對性緩解，後生元外用產品在治療和美容領域都越來越受歡迎。

高昂的製造成本和複雜的製造程序

與傳統活性成分不同，後生元需要精確的發酵、純化和穩定步驟才能保持其功效。這些過程通常需要專用設備和熟練人員，從而增加了營運成本。此外，監管合規和品質保證通訊協定也會增加成本負擔。對於新興品牌和配方商而言，這些障礙會限制其規模化生產和價格競爭力，儘管消費者興趣日益成長，但市場滲透速度仍然緩慢。

開發創新後生元配方，以解決特定的皮膚問題

透過將生物活性代謝物與互補成分結合，品牌可以開發出兼具美容和治療功能的多功能產品。封裝技術和遞送系統的創新正在提高產品的穩定性和皮膚吸收率，進一步擴大其潛在應用範圍。此外，消費者對有益於微生物群的護膚產品的需求日益成長，推動了研發投入，為產品差異化和高階定位鋪平了道路，尤其是在臨床級和健康導向型產品線方面。

其他護膚活性成分的激烈競爭

後生元外用市場面臨來自成熟護膚活性成分（如類視色素、胜肽、神經醯胺和菸鹼醯胺）的激烈競爭。這些成分擁有多年消費者信賴、廣泛的臨床檢驗以及涵蓋各種價格分佈的廣泛供應等優勢。因此，後生元不僅要在功效上競爭，還要在成本、認知度和品牌忠誠度方面與之抗衡。此外，圍繞微生物組健康的行銷宣傳仍在不斷發展，這可能會阻礙消費者的理解。

新冠疫情的影響：

新冠疫情初期擾亂了益生元外用產品的供應鏈和生產營運，導致產品上市延遲和原料採購困難。然而，這場危機也加速了消費者對皮膚健康和免疫力的關注，推動了對支持微生物群配方產品的需求。螢幕使用時間的增加和口罩的廣泛佩戴導致皮膚刺激普遍存在，促使消費者轉向修復皮膚屏障和抗炎產品。電子商務和線上護膚諮詢的興起進一步推動了市場的復甦。

預計在預測期內，乳霜和乳液細分市場將佔據最大的市場佔有率。

預計在預測期內，乳霜和乳液類產品將佔據最大的市場佔有率。這是因為乳霜和乳液因其易於塗抹、親膚親和性且適用於所有年齡層，仍然是後生元外用產品的首選劑型。這些劑型能夠有效分散生物活性化合物，並被廣泛應用於治療和美容護理中。它們具有保濕、舒緩和強化皮膚屏障的功效，使其成為後生元成分的理想載體。此外，各大品牌正擴大將後生元添加到日常保濕霜和精華液中，進一步鞏固了其市場主導地位。

預計在預測期內，抗衰老和屏障修復領域將呈現最高的複合年成長率。

預計在預測期內，抗衰老齡化和屏障修復領域將實現最高成長率，這主要得益於消費者對年輕健康肌膚日益成長的需求。後生元因其促進細胞更新、減少氧化壓力和增強皮膚微生物群的作用而備受認可。這些益處與消費者對非侵入性、對微生物群友善的抗衰老齡化解決方案日益成長的需求相契合。此外，後生元溫和地取代了刺激性強的活性成分，使其適用於成熟和敏感肌膚。臨床研究和高級產品的推出也進一步推動了該領域的成長。

佔比最大的地區：

預計北美將在預測期內佔據最大的市場佔有率，這主要得益於其先進的護膚產業、較高的消費者意識和強大的分銷網路。該地區擁有強大的研發能力，並率先應用了微生物組科學，同時消費者對潔淨標示和功能性護膚的偏好也推動了市場成長。此外，美國和加拿大的主要品牌和皮膚科醫生正在積極推廣添加後生元的產品，進一步提升了市場滲透率。

複合年成長率最高的地區：

由於可支配收入增加、美容意識增強以及對皮膚健康解決方案的需求不斷成長，預計亞太地區在預測期內將實現最高的複合年成長率。該地區充滿活力的電子商務環境和網主導行銷正在加速產品的普及。此外，當地製造商正在加大對後生元的研究和開發投入，以開發出更具成本效益且符合當地文化習慣的配方。這一發展勢頭使亞太地區成為市場成長的關鍵引擎。

免費客製化服務

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 原始研究資料
    • 二手研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 市場機遇
  • 威脅
  • 產品分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 公司間的競爭

5. 全球後生元外用市場（依產品類型分類）

  • 介紹
  • 乳霜和乳液
  • 美容精華/濃縮液
  • 凝膠和軟膏
  • 口罩及貼片
  • 噴霧/霧
  • 其他產品類型

6. 全球後生元外用產品市場（依活性成分分類）

  • 介紹
  • 基於短鏈脂肪酸（SCFA）的後生元
  • 細菌裂解液和細胞分離上清液
  • 細胞外多醣體及其組成
  • 發酵衍生的代謝物
  • 混合配方和多效配方

7. 全球後生元外用產品市場（依應用領域分類）

  • 介紹
  • 敏感肌膚和易泛紅肌膚
  • 用於治療異位性皮膚炎和濕疹的輔助藥物
  • 痤瘡和皮脂調節
  • 抗衰老和屏障修復
  • 創傷治療/術後護理
  • 色素沉著和膚色矯正

8. 全球後生元外用市場（依最終用戶分類）

  • 介紹
  • 皮膚科診所和處方藥物治療
  • 護膚品牌、非處方藥零售商
  • 美容及個人護理
  • 電子商務/D2C品牌
  • 水療、專業美容護理

9. 全球後生元外用產品市場（依分銷通路分類）

  • 介紹
  • 藥局/藥局連鎖店
  • 美容零售商、百貨公司
  • 電子商務平台、品牌網站
  • 專業頻道
  • 直銷和訂閱模式

第10章 全球後生元外用市場（依地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Cargill, Incorporated
  • Archer Daniels Midland Company
  • Kerry Group plc
  • dsm-firmenich
  • Associated British Foods plc
  • BASF SE
  • Novonesis
  • International Flavors & Fragrances Inc.
  • MCLS Europe BV
  • Lesaffre Group
  • Lallemand Inc.
  • Sami-Sabinsa Group Limited
  • CJ CheilJedang Corporation
  • Biotenova Sdn. Bhd.
  • Bioprox Healthcare
  • Church & Dwight Co., Inc.
Product Code: SMRC32196

According to Stratistics MRC, the Global Postbiotic Topicals Market is accounted for $138.2 million in 2025 and is expected to reach $267.7 million by 2032, growing at a CAGR of 9.9% during the forecast period. Postbiotic topicals are skincare formulations infused with non-living microbial byproducts such as enzymes, peptides, and metabolites that support skin health. Postbiotics do not contain live bacteria, making them more stable and suitable for topical use. These bioactive compounds help reinforce the skin barrier, reduce inflammation, and promote a balanced microbiome. Widely used in dermatology and cosmetic applications, postbiotic topicals offer targeted benefits for sensitive, acne-prone, or aging skin without the risks associated with live cultures.

Market Dynamics:

Driver:

Rising prevalence of skin conditions like acne, eczema, and sensitivity

Acne, eczema, and sensitivity conditions have heightened consumer awareness around microbiome-friendly skincare, prompting interest in non-irritating, barrier-supportive formulations. Postbiotics offer anti-inflammatory and soothing benefits without the instability of live cultures, making them ideal for sensitive skin. This trend is further reinforced by clinical endorsements and growing demand for clean-label products. As consumers seek targeted relief, postbiotic topicals are gaining traction across both therapeutic and cosmetic applications.

Restraint:

High production costs and complex manufacturing processes

Unlike conventional actives, postbiotics require precise fermentation, purification, and stabilization steps to retain efficacy. These processes often demand specialized equipment and skilled personnel, increasing operational overheads. Additionally, regulatory compliance and quality assurance protocols add to the cost burden. For emerging brands and formulators, these barriers can limit scalability and price competitiveness, thereby slowing broader market penetration despite rising consumer interest.

Opportunity:

Development of innovative postbiotic blends for targeted skin concerns

By combining bioactive metabolites with complementary ingredients, brands can create multifunctional products that address both aesthetic and therapeutic needs. Innovations in encapsulation and delivery systems are enhancing stability and skin absorption, further expanding application potential. Moreover, consumer demand for microbiome-supportive skincare is encouraging R&D investments. This opens avenues for differentiation and premium positioning, especially in clinical-grade and wellness-focused product lines.

Threat:

Intense competition from other skincare active ingredients

The postbiotic topicals market is challenged by intense competition from established skincare actives such as retinoids, peptides, ceramides, and niacinamide. These ingredients have long-standing consumer trust, extensive clinical validation, and widespread availability across price tiers. As a result, postbiotics must compete not only on efficacy but also on cost, familiarity, and brand loyalty. Furthermore, marketing claims around microbiome health are still evolving, which may hinder consumer understanding.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted supply chains and manufacturing operations for postbiotic topicals, delaying product launches and limiting ingredient availability. However, the crisis also accelerated consumer interest in skin health and immunity, driving demand for microbiome-supportive formulations. Increased screen time and mask usage led to widespread skin irritation, prompting a shift toward barrier-repair and anti-inflammatory products. E-commerce growth and digital skincare consultations further supported market recovery.

The creams & lotions segment is expected to be the largest during the forecast period

The creams & lotions segment is expected to account for the largest market share during the forecast period as creams and lotions remain the most preferred format for postbiotic topical delivery due to their ease of application, skin compatibility, and versatility across age groups. These formats allow for effective dispersion of bioactive compounds and are widely accepted in both therapeutic and cosmetic routines. Their ability to hydrate, soothe, and reinforce the skin barrier makes them ideal carriers for postbiotic ingredients. Moreover, brands are increasingly integrating postbiotics into daily-use moisturizers and serums, reinforcing their dominance in the market.

The anti-aging & barrier repair segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the anti-aging & barrier repair segment is predicted to witness the highest growth rate driven by rising consumer demand for skin longevity and resilience. Postbiotics are gaining recognition for their role in enhancing cellular renewal, reducing oxidative stress, and fortifying the skin's microbiome. These benefits align with the growing preference for non-invasive, microbiome-friendly anti-aging solutions. Additionally, postbiotics offer a gentler alternative to harsh actives, making them suitable for mature and sensitive skin. This segment's growth is further supported by clinical studies and premium product launches.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its advanced skincare industry, high consumer awareness, and robust distribution networks. The region benefits from strong R&D capabilities and early adoption of microbiome science and growing preference for clean-label and functional skincare boosts this regions market. Moreover, leading brands and dermatologists in the U.S. and Canada are actively promoting postbiotic formulations, further driving market penetration.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rising disposable incomes, expanding beauty consciousness, and increasing demand for skin health solutions. The region's dynamic e-commerce landscape and influencer-driven marketing are accelerating product adoption. Additionally, local manufacturers are investing in postbiotic R&D, contributing to cost-effective and culturally tailored formulations. This momentum positions Asia Pacific as a key growth engine for the market.

Key players in the market

Some of the key players in Postbiotic Topicals Market include Cargill, Incorporated, Archer Daniels Midland Company, Kerry Group plc, dsm-firmenich, Associated British Foods plc, BASF SE, Novonesis, International Flavors & Fragrances Inc., MCLS Europe B.V., Lesaffre Group, Lallemand Inc., Sami-Sabinsa Group Limited, CJ CheilJedang Corporation, Biotenova Sdn. Bhd., Bioprox Healthcare, and Church & Dwight Co., Inc.

Key Developments:

In October 2025, Cargill has conducted human clinical trials highlighting their postbiotic raw material EpiCor, a dried fermentate from Saccharomyces cerevisiae. Results show anti-inflammatory properties and positive effects on skin inflammation when applied topically, reducing microvascular inflammatory responses and irritation in skin models.

In June 2025, dsm-firmenich Animal Nutrition & Health has announced the launch of GutServ(R) Biotics, an innovative postbiotic solution designed to support piglet health, resilience and performance.

In February 2025, ADM a global leader in innovative solutions from nature, announced today its agreement with Asahi Group Foods Corporation, a leading food company headquartered in Japan, to exclusively market and distribute Asahi Group's proprietary lactic acid-based postbiotic, Lactobacillus gasseri CP2305.

Product Types Covered:

  • Creams & Lotions
  • Serums & Concentrates
  • Gels & Ointments
  • Masks & Patches
  • Sprays & Mists
  • Other Product Types

Active Ingredients Covered:

  • Short-chain fatty acid (SCFA)-based postbiotics
  • Bacterial lysates & cell-free supernatants
  • Exopolysaccharides & polysaccharide fractions
  • Fermentation-derived metabolites
  • Blends & Multi-active Formulations

Applications Covered:

  • Sensitive & Redness-prone Skin
  • Atopic Dermatitis & Eczema adjuncts
  • Acne & Sebum Regulation
  • Anti-Aging & Barrier Repair
  • Wound Healing / Post-procedural Care
  • Hyperpigmentation & Tone Correction

End Users Covered:

  • Dermatology Clinics & Prescribable Treatments
  • Dermatocosmetic Brands & OTC Retail
  • Beauty & Personal Care
  • E-commerce / D2C brands
  • Spas & Professional Aesthetics

Distribution Channels Covered:

  • Pharmacies & Drugstore Chains
  • Beauty Retailers & Department Stores
  • E-Commerce Marketplaces & Brand Websites
  • Professional Channels
  • Direct Sales & Subscription Models

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Postbiotic Topicals Market, By Product Type

  • 5.1 Introduction
  • 5.2 Creams & Lotions
  • 5.3 Serums & Concentrates
  • 5.4 Gels & Ointments
  • 5.5 Masks & Patches
  • 5.6 Sprays & Mists
  • 5.7 Other Product Types

6 Global Postbiotic Topicals Market, By Active Ingredient

  • 6.1 Introduction
  • 6.2 Short-chain fatty acid (SCFA)-based postbiotics
  • 6.3 Bacterial lysates & cell-free supernatants
  • 6.4 Exopolysaccharides & polysaccharide fractions
  • 6.5 Fermentation-derived metabolites
  • 6.6 Blends & Multi-active Formulations

7 Global Postbiotic Topicals Market, By Application

  • 7.1 Introduction
  • 7.2 Sensitive & Redness-prone Skin
  • 7.3 Atopic Dermatitis & Eczema adjuncts
  • 7.4 Acne & Sebum Regulation
  • 7.5 Anti-Aging & Barrier Repair
  • 7.6 Wound Healing / Post-procedural Care
  • 7.7 Hyperpigmentation & Tone Correction

8 Global Postbiotic Topicals Market, By End User

  • 8.1 Introduction
  • 8.2 Dermatology Clinics & Prescribable Treatments
  • 8.3 Dermatocosmetic Brands & OTC Retail
  • 8.4 Beauty & Personal Care
  • 8.5 E-commerce / D2C brands
  • 8.6 Spas & Professional Aesthetics

9 Global Postbiotic Topicals Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Pharmacies & Drugstore Chains
  • 9.3 Beauty Retailers & Department Stores
  • 9.4 E-Commerce Marketplaces & Brand Websites
  • 9.5 Professional Channels
  • 9.6 Direct Sales & Subscription Models

10 Global Postbiotic Topicals Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Cargill, Incorporated
  • 12.2 Archer Daniels Midland Company
  • 12.3 Kerry Group plc
  • 12.4 dsm-firmenich
  • 12.5 Associated British Foods plc
  • 12.6 BASF SE
  • 12.7 Novonesis
  • 12.8 International Flavors & Fragrances Inc.
  • 12.9 MCLS Europe B.V.
  • 12.10 Lesaffre Group
  • 12.11 Lallemand Inc.
  • 12.12 Sami-Sabinsa Group Limited
  • 12.13 CJ CheilJedang Corporation
  • 12.14 Biotenova Sdn. Bhd.
  • 12.15 Bioprox Healthcare
  • 12.16 Church & Dwight Co., Inc.

List of Tables

  • Table 1 Global Postbiotic Topicals Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Postbiotic Topicals Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Postbiotic Topicals Market Outlook, By Creams & Lotions (2024-2032) ($MN)
  • Table 4 Global Postbiotic Topicals Market Outlook, By Serums & Concentrates (2024-2032) ($MN)
  • Table 5 Global Postbiotic Topicals Market Outlook, By Gels & Ointments (2024-2032) ($MN)
  • Table 6 Global Postbiotic Topicals Market Outlook, By Masks & Patches (2024-2032) ($MN)
  • Table 7 Global Postbiotic Topicals Market Outlook, By Sprays & Mists (2024-2032) ($MN)
  • Table 8 Global Postbiotic Topicals Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Postbiotic Topicals Market Outlook, By Active Ingredient (2024-2032) ($MN)
  • Table 10 Global Postbiotic Topicals Market Outlook, By Short-chain Fatty Acid (SCFA)-based Postbiotics (2024-2032) ($MN)
  • Table 11 Global Postbiotic Topicals Market Outlook, By Bacterial Lysates & Cell-free Supernatants (2024-2032) ($MN)
  • Table 12 Global Postbiotic Topicals Market Outlook, By Exopolysaccharides & Polysaccharide Fractions (2024-2032) ($MN)
  • Table 13 Global Postbiotic Topicals Market Outlook, By Fermentation-derived Metabolites (2024-2032) ($MN)
  • Table 14 Global Postbiotic Topicals Market Outlook, By Blends & Multi-active Formulations (2024-2032) ($MN)
  • Table 15 Global Postbiotic Topicals Market Outlook, By Application (2024-2032) ($MN)
  • Table 16 Global Postbiotic Topicals Market Outlook, By Sensitive & Redness-prone Skin (2024-2032) ($MN)
  • Table 17 Global Postbiotic Topicals Market Outlook, By Atopic Dermatitis & Eczema Adjuncts (2024-2032) ($MN)
  • Table 18 Global Postbiotic Topicals Market Outlook, By Acne & Sebum Regulation (2024-2032) ($MN)
  • Table 19 Global Postbiotic Topicals Market Outlook, By Anti-Aging & Barrier Repair (2024-2032) ($MN)
  • Table 20 Global Postbiotic Topicals Market Outlook, By Wound Healing / Post-procedural Care (2024-2032) ($MN)
  • Table 21 Global Postbiotic Topicals Market Outlook, By Hyperpigmentation & Tone Correction (2024-2032) ($MN)
  • Table 22 Global Postbiotic Topicals Market Outlook, By End User (2024-2032) ($MN)
  • Table 23 Global Postbiotic Topicals Market Outlook, By Dermatology Clinics & Prescribable Treatments (2024-2032) ($MN)
  • Table 24 Global Postbiotic Topicals Market Outlook, By Dermatocosmetic Brands & OTC Retail (2024-2032) ($MN)
  • Table 25 Global Postbiotic Topicals Market Outlook, By Beauty & Personal Care (2024-2032) ($MN)
  • Table 26 Global Postbiotic Topicals Market Outlook, By E-commerce / D2C Brands (2024-2032) ($MN)
  • Table 27 Global Postbiotic Topicals Market Outlook, By Spas & Professional Aesthetics (2024-2032) ($MN)
  • Table 28 Global Postbiotic Topicals Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 29 Global Postbiotic Topicals Market Outlook, By Pharmacies & Drugstore Chains (2024-2032) ($MN)
  • Table 30 Global Postbiotic Topicals Market Outlook, By Beauty Retailers & Department Stores (2024-2032) ($MN)
  • Table 31 Global Postbiotic Topicals Market Outlook, By E-Commerce Marketplaces & Brand Websites (2024-2032) ($MN)
  • Table 32 Global Postbiotic Topicals Market Outlook, By Professional Channels (2024-2032) ($MN)
  • Table 33 Global Postbiotic Topicals Market Outlook, By Direct Sales & Subscription Models (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.